Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
American College of Surgeons Recognizes ChristianaCare for ‘Meritorious’ Surgical Outcomes
ChristianaCare has been honored as one of only 78 institutions out of 615 by the American College of Surgeons (ACS) Clinical Congress for achieving “meritorious” outcomes in surgical patient care. This is the 10th time that ChristianaCare has been recognized through the organization’s National Surgical Quality Improvement Program – also known as ACS NSQIP – which is the only nationally validated quality improvement program that measures and enhances the care of surgical patients. “Patients can be confident that when they come to ChristianaCare for surgery, they are receiving care from a team that has a long track record of national recognition for outstanding quality and safety. Receiving this recognition for the 10th time is a direct result of our commitment to excellence and providing world-class surgical care to our community,” said Matthew Rubino, MD, MBA, FACS, interim chair of ChristianaCare’s Department of Surgery. “These awards reflect the commitment to excellence by all our surgeons and caregivers within Perioperative Services. We look forward to progressing on our journey of continuous improvement, anchored by our values of love and excellence.” The award recognizes ChristianaCare’s coordinated delivery of perioperative care within the general, colorectal, neurologic, orthopaedic and oral and maxillofacial and otorhinolaryngology (ear, nose and throat) surgery specialties. It includes Christiana Hospital and Wilmington Hospital, as well as the Christiana Surgicenter in Newark, Delaware, representing a combined total of nearly 38,000 surgical procedures a year. That volume represents the 46th highest volume of surgeries among health systems nationwide. The ACS NSQIP measures actual surgical results 30 days after the operation and makes risk adjustments to compensate for differences among patient populations and acuity levels. Participating hospitals are required to track the outcomes of inpatient and outpatient surgical procedures and then analyze their results, which direct patient safety initiatives within the hospital and impact the quality of surgical care. ChristianaCare was honored with ACS NSQIP recognition for its performance in eight clinical areas: Mortality. Cardiac arrest and heart attack. Pneumonia. Unplanned intubation. Ventilator use for longer than 48 hours. Renal failure. Surgical site infections. Urinary tract infection.
Since 2022, the U.S. Food and Drug Administration has been actively urging consumers to avoid purchasing or consuming tianeptine -- a synthetic drug commonly called "gas station heroin" that can mimic the actions of opioids like fentanyl. Now, the FDA is upping the urgency of it's warnings as vendors continue to market the drug as a so-called "dietary supplement." UConn's C. Michael White, a Distinguished Professor of Pharmacy Practice, spoke with The Conversation about the problem with tianeptine in a must-read Q-and-A: What is tianeptine and why is it risky? Tianeptine stimulates the same receptors as well-known opioids such as fentanyl, heroin and morphine. When these drugs make their way from the blood to the brain, they bind to the “mu” type opioid receptor that triggers the sought-after pain relief and euphoria of those drugs as well as the dangerous effects like slowed or stopped breathing. High doses of tianeptine can bring euphoric effects similar to heroin and can also bring about the dissociative effect – the perception of your mind being disconnected from your surroundings and body – that is reminiscent of ketamine, an anesthetic that has a role in treating post-traumatic stress disorder and depression but has also commonly been abused as a street drug. Products containing tianeptine are often called “legal high drugs” – sometimes dubbed “gas station drugs” – a term used for all non-FDA-approved synthetic drugs that are sold casually in gas stations, online and elsewhere. What are the major adverse effects that people can experience? Data from clinical trials, case reports and poison control centers shows that tianeptine commonly induces agitation. This is typically accompanied by a fast heart rate and high blood pressure, confusion, nightmares, drowsiness, dry mouth and nausea, among other conditions. The most serious adverse events are slowed or stopped breathing, coma, heart arrhythmia and death. When long-term users try to stop tianeptine use, they often experience withdrawal symptoms reminiscent of opioid withdrawal. Consumers need to be aware that products containing tianeptine may not adhere to good manufacturing practices. This means they could contain lead or have other heavy metal contamination or be contaminated by microorganisms such as salmonella or mold. They could also contain other drug ingredients that are not disclosed. Knowingly or unknowingly combining active ingredients can increase the risk of adverse events. Additionally, the amount of the active ingredient contained in the product can vary widely, even with the same manufacturer. So past use does not guarantee that using the same amount will provide the same effect. How are these drugs sold in the US if they are not FDA-approved? If a drug product is not FDA-approved for prescription or over-the-counter-use, it is the Drug Enforcement Agency that is responsible for controlling market access. Before the DEA can ban an active ingredient in a drug product, it must be designated Schedule I, meaning the drug has no legitimate medical purpose and has high abuse potential. Manufacturers do not have to alert the DEA before selling their products to U.S. citizens. This means the DEA must detect an issue, identify the products causing the issue, identify the active ingredients in the product in question and do a full scientific review before designating it as Schedule I. Tianeptine came to market masquerading as a dietary supplement in gas stations and smoke shops, even though it is a synthetic compound. Tianeptine is also sold online allegedly for research purposes and not for human consumption. Tianeptine is undergoing clinical trials for the treatment of pain and depression, but sellers do nothing to make this type of labeling clear to consumers or to restrict purchases to researchers. What can people do to protect themselves and their families? Non-FDA-approved products containing synthetic drugs are very risky to use and should be avoided. FDA-approved drugs are available by a prescription from a health professional or over the counter with active ingredients on an approved list. If someone in a gas station, smoke shop or over the internet touts the benefits of a non-FDA-approved drug product – for pain or anxiety relief, to increase energy or for a buzz – be aware. It could be dangerous the first time you use it, but using it successfully once also doesn’t mean the experience will be the same the next time, and continued use can cause addiction. If a product is being sold “not for human consumption” or “for research purposes only,” you are at a high risk if you take it. Before you take any dietary supplement, make sure you check the active ingredient to be sure that it is, in fact, a natural product and not a synthetic chemical. If someone you know has bags with unmarked powder, a product labeled for research use or not for human consumption, or tablets or capsules not in standard drug bottles, that is a sign of a potentially dangerous situation. Standard drug tests sold over the counter are not designed to pick up tianeptine. One of the main reasons that people use these alternative substances of abuse over regular opioids, cannabis or amphetamines is that they are much harder to detect through work- or at-home drug screens by parents, schools, employers, probation officers and so on. If the DEA is not responding to emerging threats quickly enough, individual states can also act to ban sales of dangerous active ingredients in products. As of January 2024, at least 12 states have banned the sale of tianeptine, according to the FDA, although people in those states can still illegally procure it from the internet. So contacting your state legislators could be a place to start exercising your power to help prevent the harms from these products. This is an important piece, and if you are looking to know about tianeptine and the threat it poses to consumers in America, then let us help. Dr. C. Michael White is an expert in the areas of comparative effectiveness and preventing adverse events from drugs, devices, dietary supplements, and illicit substances. Dr. White is available to speak with media -- click on his icon now to arrange an interview today.
In a recent survey conducted by CAA South Central Ontario (CAA SCO), alarming trends indicate a significant rise in cannabis-impaired driving, particularly involving edibles. Key findings from the 2023 survey revealed that 38 per cent of cannabis-impaired drivers in Ontario consumed edibles before driving—a 12 per cent increase from the previous year and more than double the rate in 2019. “The data shows us that while drivers primarily engage in cannabis-impaired driving after smoking a joint, the prevalence of driving under the influence of edibles is on the upswing, and that poses a greater risk to road safety,” says Michael Stewart, community relations consultant at CAA SCO. “Edibles are harder to detect and can take up to two hours for the effects to kick in.” According to the survey, 7 per cent (approximately 750,000 Ontario drivers) admit to driving after consuming some form of cannabis in the past three months. The survey also found that almost three-quarters (70 per cent) of the cannabis-impaired drivers admitted to getting behind the wheel within 3 hours of consumption, and nearly half (45 per cent) have felt high while driving. “Despite the misconception that cannabis may not impair driving ability, it affects coordination, reaction time, attention, judgment, and decision-making. We want to emphasize our commitment to public education, urging motorists to stay informed about the risks and penalties of impaired driving,” says Stewart. The consequences of impaired driving are evident, with 6 per cent of Ontario drivers admitting having ever been charged— an increase from the previous year. Collisions caused by impaired driving also rose to 6 per cent in 2023, compared to 4 per cent in the preceding year. During this holiday season, CAA reminds drivers to make alternate arrangements, such as utilizing rideshare services, to ensure a safe journey home. “While edibles may be legal, CAA emphasizes that they are incompatible with responsible driving,” adds Stewart. Dig Insights conducted an online survey on behalf of CAA SCO between June 22 to July 5, 2023, of 1,518 Ontario drivers aged 19-75 who had access to a vehicle. Based on the sample size and the confidence level (95 per cent), the margin of error for this study was +/- 2 per cent.
University of Delaware researcher one of 500 contributors to Fifth National Climate Assessment
A.R. Siders, core faculty with the University of Delaware's Disaster Research Center, is one of 500-plus experts who developed the Fifth National Climate Assessment (NCA5), the preeminent source of authoritative information on the risks, impacts and responses to climate change in the United States. Leaders and practitioners highlighted the findings and raised awareness of climate impacts and solutions at a release event on Nov. 14. White House and climate leaders from across the country elevated the key themes of NCA5 and further highlight the Biden Administration’s whole-of-government approach to mitigating and adapting to climate change. Siders focuses on managed retreat, which is the purposeful movement of people, buildings and other assets from areas vulnerable to hazards. She also specializes in climate change adaptation decision-making and evaluation in general: how and why communities decide when, where, and how to adapt to the effects of climate change and how these decisions affect risk reduction and equity outcomes. Joining Siders on the NCA5 were Jing Gao, Assistant Professor of Geospatial Data Science, and Kimberly Oremus, assistant professor of marine science and policy. Siders is available for interviews. Click on her profile to connect.
Georgia Southern’s public health center receives $4 million to assist rural hospitals nationwide
Georgia Southern University’s Center for Public Health Practice and Research at the Jiann-Ping Hsu College of Public Health (JPHCOPH) received a $4 million grant from the Health Resources and Services Administration (HRSA) to provide targeted technical assistance to rural hospitals nationwide. The funding will support the team’s implementation of the Targeted Technical Assistance for Rural Hospitals Program over a five-year period (2023-2028). “Many rural hospitals are struggling financially across the U.S.,” said JPHCOPH Dean Stuart Tedders, Ph.D. “Long-term, the primary program goal of this grant is to ensure that all rural hospitals are financially viable and positioned to serve their communities with the essential health care services that we all need and expect. A viable health care system is essential for assuring that all communities and their residents thrive. I am very proud of the Center for Public Health Practice and Research at the JPHCOPH and the commitment they have made to improving the quality of life of rural and underserved populations across the country.” Bettye Apenteng, Ph.D., and Charles Owens, both professors of health policy and management, serve as the co-principal investigators for the grant. “We are proud to be selected to work cooperatively with rural hospitals across the U.S. to strengthen their viability so they can continue to provide essential health care locally so the residents, the local hospital and the community may thrive,” said Owens. As part of this cooperative agreement, the team will work in partnership with HRSA and rural health stakeholders to provide in-depth and tailored technical assistance to rural hospitals at risk of financial distress nationwide. Technical assistance delivered as part of this program will help rural hospital communities implement a prioritized strategy for maintaining essential services locally through capacity building in evidence-based decision-making, operational and financial improvement, strategic management, community partnership, project implementation and evaluation. “We are excited to extend the work we have done in Georgia with rural hospitals, for close to a decade, to the rest of the nation,” said Apenteng. “We look forward to building strong collaborative relationships with rural hospital communities nationwide.” The grant activities will be executed by a multidisciplinary team that includes additional JPHCOPH faculty Angie Peden; Andrew Hansen, DrPH; Linda Kimsey, Ph.D.; William Mase, DrPH; Tilicia Mayo-Gamble, Ph.D., and Samuel Opoku, Ph.D.; and Parker College of Business’ Kwabena Boakye, Ph.D.; and the College of Arts and Humanities’ Jason Murdock. Interested in learning more or looking to talk with Bettye Apenteng, Ph.D., and Charles Owens about this grant? Simply click on an expert's icon or contact Georgia Southern's Director of Communications Jennifer Wise at jwise@georgiasouthern.edu to arrange an interview today.
Expert reaction to the UK AI Safety Summit
Today the UK government announced a "world first agreement" on how to manage the riskiest forms of AI. It focuses on so-called "frontier AI" - what ministers consider highly advanced forms of the tech - with as-yet unknown capabilities. The agreement, signed by countries including the US, the EU and China, was announced at the UK's AI Safety Summit. Dr Alina Patelli, Senior Lecturer in Computer Science, Aston University, comments: “A summit on AI safety is long overdue. As is the case with all groundbreaking technologies, AI’s transformative potential for public good is only matched by its risks, which are unlikely to be successfully avoided, if AI tech design and deployment are left unregulated and therefore open to misuse, either intentionally or accidentally. The scope of the summit is appropriate, reflective of Government’s cautious approach to managing interactions with AI safety experts from multiple nations and disciplines: the summit focus is kept narrow, to five objectives only, and the number of participants is wisely limited to 100, to keep the conversation productive.” What is likely to come out of this summit? “The summit’s main output will most likely be a bare-bones regulatory document comprising (1) a shared understanding of AI (i.e., a generally accepted definition of the term reflective of all summit participants’ views, not just those of tech experts), (2) a list of major risks associated to AI misuse, both in terms of potential damage as well as likelihood of becoming a reality, and (3) a policy draft outlining the core elements that a yet-to-be-developed governance framework should include.” What AI safety could/should look like? “Although it would be premature to venture a definition of AI safety ahead of the summit, one thing that is certain is that a comprehensive, therefore effective, AI regulatory framework would encompass more than just laws. Non-legally binding codes of conduct, tech design and development processes that are bound by moral and ethical values, both in the commercial ecosystem, as well as when it comes to individual entrepreneurs, revised open-access licenses under which AI should be used in the public domain, etc. are equally important pieces. The best way to integrate all these in a cohesive, overarching governance plan is perhaps a topic to explore in one of the post-summit events.” What are the potential practicalities for a route forward towards safe AI? “The practical way to systematically regulate AI is incremental. Initially, the development and application of those AI tools deemed to be high-risk will most likely be restricted to controlled environments, where the potential benefits justify the risks and where sound mitigation procedures can be quickly and effectively enforced to mitigate those risks. As regulations become better prescribed, AI’s (safe and legal) application space will gradually expand, making its benefits available to larger groups of people without any of the downsides.” To interview Dr Alina Patelli or request further details contact Nicola Jones, Press and Communications Manager, on (+44) 7825 342091 or email: n.jones6@aston.ac.uk
Aston University fraud specialist continues ongoing engagement with UK Government
Dr Rasha Kassem advises UK government on countering fraud through the Government Counter Fraud Profession (GCFP) advisory group She shapes policies to combat £33 billion annual losses Dr Kassem influences fraud standards and shares vital research. Dr Rasha Kassem, a fraud specialist based at Aston Business School, remains actively engaged with the UK government through her advisory role in the Government Counter Fraud Profession (GCFP) advisory group. This advisory group, a vital component of the Government Counter Fraud Function, collaborates with cross-sector experts to shape policies and strategies aimed at countering fraud and other financial crimes. The Government Counter Fraud Profession Strategy 2023-25 underscores the severity of fraud within the public sector, estimating losses at a minimum of £33 billion annually due to fraud and error. As a dedicated member of the GCFP Cross Sector Advisory Group, Dr Kassem plays a pivotal role in advising and supporting the development of policies to combat these financial crimes. The GCFP serves as a professional body for counter-fraud experts within central government and beyond. Its mission is to unite the counter-fraud community under a common framework of standards, fostering growth and development to safeguard public services and combat economic crime. Dr Kassem's involvement in the advisory group holds significant impact, influencing the establishment of knowledge, skills and experience requirements for fraud professionals across various disciplines and levels. Additionally, she contributes to the publication of influential fraud research in the Public Sector Counter Fraud Journal and addresses UK government fraud conferences on recent research findings. Dr Kassem also collaborates with experts from diverse sectors to bridge training gaps, all while engaging in discussions through regular group meetings. The Government Counter Fraud Profession operates under the umbrella of the Public Sector Fraud Authority (PSFA), established in August 2022. The GCFP is positioned within the Practice, Standards, and Capability Function of the Authority. The PSFA, a collective effort by 17 public sector organisations, adheres to core principles of building capability, with the GCFP taking a lead role in advancing structures and services. Dr Kassem emphasises the critical nature of engaging with policymakers through knowledge exchange activities to amplify research impact. Her active participation in UK Government fraud conferences and contributions to the Public Sector Counter Fraud Journal serve to raise awareness on prevailing fraud issues. Furthermore, her feedback on existing and new fraud guidance aids the GCFP in crafting professional standards and guidance for countering fraud. Dr Kassem has been a valued member of the Cross-Sector Advisory Group of the UK Government Counter Fraud Profession since 2019. Dr Kassem said: “Collaborating with the UK government through the Government Counter Fraud Profession has been a rewarding journey. “It's through these engagements that we're shaping policies and standards to counter fraud and protect public resources. “The recent Annual GCFP conference was well attended by fraud investigators, law enforcement, and regulators from the public sector. My presentation was well received and some participants said it was wildly fascinating to hear the striking reality that insider fraud can be, especially in UK policing, given its impact on policing integrity and legitimacy. The presentation opened their eyes to the risk of insider fraud and its impact. “Together, we're making a significant impact on the battle against financial crime.” For further information and to explore Dr Kassem's recent research, click here.
Widening rift with Canada puts India's relations with the West at risk
Relations between India and Canada continue to devolve after Canadian Prime Minister Justin Trudeau accused India of playing a part in the assassination of a Sikh activist on its home soil. Following India's denial, both countries expelled senior diplomats. In a new video posted on his YouTube channel, Professor Muqtedar Khan said relations are spiraling toward a dangerous place. And, he added, if the situation continues to devolve, it could have a major impact on India's relations with the entire Western world. Khan, a professor of political science and international relations, is an expert on issues surrounding U.S. foreign policy in the Muslim World as well as national security and counter-terrorism. He can also discuss: The Khalistan Movement: The Sikh separatist movement that has taken many lives since the 1980s including the assassination of India's former PM Indira Gandhi. How Canada's large Sikh population 770,000 (2.1%) makes it a hotbed of Sikh activism. In 1985, Canadians Sikh exploded an Air India flight from Montreal to London killing 329 people The assassination of Hardeep Singh Nijjar and its diplomatic fallout. The dispute between Canada and India is over the killing of Nijjar, a Canadian Sikh who was organizing an illegal referendum on separatism. Khan is the author of "Islam and Good Governance: A Political Philosophy of Ihsan." Video of Khan discussing the concept of Ihsan can be found here. He has also drawn a large following with his "Khanversations" channel on YouTube. To schedule an interview, click on the contact button found in his ExpertFile profile.
#Expert Insight: Let’s Talk About Maternal and Postpartum Health
With increased maternal mortality rates in the news, and births involving inductions and c- sections on the rise despite their risks, Elizabeth Johnson-Young asks: 'What communication choices and strategies do women use after a negative birth experience?' Many women define certain aspects of childbirth as traumatic – from a mother or child’s life being put at risk to a host of less serious circumstances that can cause an unfavorable natal experience – and that can pose a threat to mental health. Who will they trust next when it comes to their maternal healthcare and their future decisions regarding birth? Johnson-Young’s project, “Birth, Trauma, and Communicating Maternal Health,” uses in-depth interviews of women who define their birth experience as difficult or traumatic. It focuses on choices and perceptions, and discusses the potential outcomes of listening, language and support. This is an important topic for health care providers, families and mothers and if you are looking to know more - then let us help. Dr. Elizabeth Johnson-Young is a published expert on health communication, especially maternal and family health. She is ready to help if you are looking to cover this topic - simply click on her icon now to arrange an interview today.
Immediate and long-term recovery in post-earthquake Morocco
Sunday's earthquake in Morocco – the strongest to hit the center of the country in more than a century – has taken the lives of more than 2,500 people so far and leveled countless homes and businesses. Experts from the University of Delaware's Disaster Research Center can discuss various topics related to the tragedy. Tricia Wachtendorf: Disaster relief and donations, and alignment post-disaster – i.e., making sure donations that aren't needed don't flood the supply chain. Wachtendorf can also discuss evacuation decision-making, volunteer efforts, disaster response and coordination. Rachel Davidson: Can discuss building damage, and conducts research on natural disaster risk modeling and civil infrastructure systems. Davidson looks at lifelines (e.g., electric power, water supply) and risk from a regional perspective during and after earthquakes and other disasters. Jennifer Horney: Environmental impacts of disasters and potential public health impacts for chronic and infectious diseases. Sarah DeYoung: Dealing with unsolicited infant formula donations, and infant and maternal health. Can also discuss pets in emergencies, infant feeding in disasters and decision-making in evacuation. Jennifer Trivedi: Long-term recovery and challenges for people with disabilities during disaster. Click on the profiles below to contact any of these experts and set up an interview.
